undamentalytics Newsletter

Arxis, Inc. (ARXS) stock

Add holding +

NASDAQ: ARXS Nasdaq Aerospace & Defense Next results ~January 27, 2027

Arxis, Inc. is a US-listed company in the aerospace & defense industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$33

Forward price-to-earnings vs peers

Base case. Range ~$27–$45. Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings.

Price vs value

No Buy/Hold/Sell rating is issued: limited reported history: available models are shown without a Buy/Hold/Sell rating.

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders7 buying, 0 selling7 purchases and 0 sales by directors and officers, last 12 monthsInsider trades
  • Funds133 adding, 0 cuttingOf 47 active managers that changed their stake, 47 added; quarter to June 30, 2026Fund buyers and sellers

The Fundamentalytics view

Next results ~January 27, 2027 (estimated)

Current signal Results well ahead of expectations: Reported earnings per share beat the analysts' consensus estimate by 29% in the quarter to 2026-09-30, the 2nd beat in the last four quarters.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Strengths

  • Estimates rising. Analysts' consensus for next year's earnings per share has risen 14.7% over 90 days.

Things to watch

  • Volatile shares. Over the past year the shares showed annualised volatility of 62% and a beta of 1.9 against the S&P 500.
  • Short interest rising. Shares sold short rose 60% in a month to 6.5% of tradable shares.

Latest results

Earnings per share
$0.37 against an average estimate of $0.29: beat by 29.1%
Share reaction
+11.2% in the first session after the results on July 29, 2026, against +0.1% for the S&P 500
Guidance given
revenue $1,960m to $1,980m (Full-Year 2026); adjusted EBITDA $790m to $800m (Full-Year 2026)
Next report
January 27, 2027; average EPS estimate $0.28

Arxis' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+3.2%
  • 1 week-0.6%
  • 1 month+4.6%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Earnings

Last results
July 29, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Deal
  3. Results
  4. Guidance

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: limited reported history: available models are shown without a Buy/Hold/Sell rating.

Valuation models

We value Arxis, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 10.2%: the 10-year Treasury yield (4.9%) plus a beta of 1.16 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$7.4 ~$4.1–$10 Left out: out of range vs price (0.15x)
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$33 ~$27–$45 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: no twelve-month earnings or share count in the filings yet
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: no twelve-month earnings or share count in the filings yet
Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts. — 0 Does not apply: no positive value
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. — Does not apply: revenue and margins don't support a positive value
Combined value Weighted average of the models that apply: the primary model (growth cash-flow model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$33 ~$27–$45 1 model

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Arxis, Inc. with Aerospace & Defense in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: January 27, 2027, after the close. Analysts expect revenue of $546m and EPS of $0.28 (range $0.22 to $0.35) for the quarter.

Analysts' consensus

Arxis, Inc.: consensus estimates
Fiscal yearEPSGrowthRevenueGrowth
Current $1.08 — $2.1bn +30%
Next $1.38 +28% $2.5bn +19%

Next year's EPS estimate has moved +14.7% in 90 days, across 9 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +5.9% on 90 days ago. In the last 30 days, 0 analysts raised Arxis, Inc.'s forecast and 0 cut it.

Consensus EPS forecast Arxis, Inc., last 90 days
$1.00 $1.10 $1.20 $1.30 $1.40 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $1.02 Current fiscal year, 60 days ago: $1.02 Current fiscal year, 30 days ago: $1.01 Current fiscal year, 7 days ago: $1.02 Current fiscal year, Now: $1.08 $1.08 Next fiscal year, 90 days ago: $1.21 Next fiscal year, 60 days ago: $1.34 Next fiscal year, 30 days ago: $1.29 Next fiscal year, 7 days ago: $1.32 Next fiscal year, Now: $1.38 $1.38

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $1.02$1.21
60 days ago $1.02$1.34
30 days ago $1.01$1.29
7 days ago $1.02$1.32
Now $1.08$1.38

Earnings against estimates

Arxis, Inc.: reported EPS against the consensus estimate
Quarter toEstimateActualSurprise
Sept 2026 $0.29 $0.37 +29.1%
Jun 2026 $0.19 $0.28 +48.9%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, July 29, 2026
  • Revenue Full-Year 2026 $1,960m to $1,980m Raised
    “Revenue range of $1,960 to $1,980 million, representing a 5% increase” source
  • Adjusted EBITDA Full-Year 2026 $790m to $800m Non-GAAP Raised
    “Adjusted EBITDA (1) range of $790 to $800 million, representing a 10% increase” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Analyst recommendations

11 analysts, Nov 2026
Buy11100%
Hold00%
Sell00%

Monthly trend

  1. Nov 20262911
  2. Oct 20262911
  3. Sep 202619111
  4. Aug 202619111

Counts of recommendations published by analysts covering Arxis, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
6.5%
of tradable shares
Days to cover
4.61
at average volume
Short interest, 1 month
+60%
to October 15, 2026
Held by institutions
67%
of shares
Held by insiders
13.6%
of shares
Employees
5,753
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Price behaviour

52-week range
Not enough history
From 52-week high
—
vs 50-day average
−1.0%
vs 200-day average
—
Volatility (1 year)
62%
Beta vs S&P 500
1.86

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
2 up, 0 down
typical move ±12.1%
After a week
2 up, 0 down
typical move ±20.4%
After a month
2 up, 0 down
typical move ±19.1%
Arxis, Inc.: share-price change after each results release
Results releasedNext dayS&P 500 next day5 days21 days
July 29, 2026 +11.2% +0.1% +35.3% +22.6%
May 28, 2026 +13.0% +0.8% +5.6% +15.7%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial health

1 of 3 checks passed · September 30, 2026
What it owns · $8.1bn
Short-term assets $1.3bnLonger-term assets $6.7bn
What it owes, and who funded it · $2.7bn
Short-term liabilities $284mLonger-term liabilities $2.4bn
  • Short-term assets cover short-term liabilities $1.3bn of assets due within a year against $284m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $1.3bn short-term assets against $2.4bn of longer-dated liabilities.
  • More cash than debt $494m of cash against $1.7bn of debt.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Arxis, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Reported value
$2.7B
Institutions reporting
139
Positions opened / closed
133 / 0

Top buyers and sellers, Q2 2026: 133 institutions bought and 0 sold ; the biggest buyer was T. Rowe Price Investment Management, Inc (+5.1M shares) . See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
T. Rowe Price Investment Management, Inc. $237M 5.1M 8.7% —
Jupiter Topco LLC $208M 4.5M 7.6% —
Capital International Investors $166M 3.6M 6.1% —
Capital Research Global Investors $166M 3.6M 6.1% —
Price T Rowe Associates Inc $143M 3.1M 5.2% —
Ameriprise Financial Inc $123M 2.7M 4.5% —
Blackrock, Inc. $101M 2.2M 3.7% —
Vanguard Capital Management LLC $86M 1.9M 3.1% —
Invesco Ltd. $84.6M 1.8M 3.1% —
Citadel Advisors LLC $74.2M 1.6M 2.7% —
Massachusetts Financial Services Co $72.8M 1.5M 2.7% —
Vanguard Portfolio Management LLC $69.2M 1.5M 2.5% —

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Arxis, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Recent insider open-market transactions
Insider Date Trade Shares Price Value
Roth Jason Aaron See Remarks April 17, 2026 Buy 60,000 $28.00 $1.7M
Perhamus Kevin Scott See Remarks April 17, 2026 Buy 53,600 $28.00 $1.5M
Allen Patrick E Director April 17, 2026 Buy 10,000 $28.00 $280,000
Oetgen Stephen Duane Director April 17, 2026 Buy 25,000 $28.00 $700,000
Sealfon Ross Bradley See Remarks April 17, 2026 Buy 12,500 $28.00 $350,000
Badakhsh Azad Sid See Remarks April 17, 2026 Buy 36,000 $28.00 $1M
Jankowski Ryan Anthony Chief Accounting Officer April 17, 2026 Buy 4,464 $28.00 $124,992

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

  • July 29, 2026
  • May 28, 2026

Recent SEC filings

Data status

When each part of this page on Arxis, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Arxis, Inc. in brief

What does Arxis, Inc. do?
Arxis, Inc. is a US-listed company in the aerospace & defense industry. Its financial year ends in December.
What is Arxis, Inc.'s stock ticker?
Arxis, Inc. trades under the ticker ARXS on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
Who are Arxis, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are T. Rowe Price Investment Management, Inc., Jupiter Topco LLC and Capital International Investors. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Are insiders buying or selling Arxis, Inc. stock?
Over the last 12 months, Arxis, Inc.'s directors and officers reported 7 open-market purchases and 0 sales on Form 4. The insider trading page charts every trade.
When is Arxis, Inc.'s next earnings date?
Around January 27, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Arxis, Inc. announces its own schedule.